MUC4 expression increases progressively in pancreatic intraepithelial neoplasia

American Journal of Clinical Pathology

Volumn 117, Issue 5, 2002, Pages 791-796

  Swartz, Michael J ^a   Batra, Surinder K ^a   Varshney, Grish C ^a   Hollingsworth, Michael A ^a   Yeo, Charles J ^a   Cameron, John L ^a   Wilentz, Robb E ^a   Hruban, Ralph H ^a   Argani, Pedram ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adenocarcinoma; MUC4; Mucin; Pancreas; Pancreatic intraepithelial neoplasia; PanIN

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN; MUCIN 4; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER MODEL; CARCINOMA IN SITU; CHRONIC PANCREATITIS; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA;

CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CELL COUNT; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036233702     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7Y7N-M1WM-R0YK-M2VA     Document Type: Article

References (37)

1. Cancer statistics, 2000
2. Global cancer statistics
3. Tumor-suppressive pathways in pancreatic carcinoma
4. The multistep nature of cancer
5. A genetic model for colorectal tumorigenesis
6. Pancreas
7. Progression of pancreatic intraductal neoplasias (high-grade PanIN) to infiltrating adenocarcinoma of the pancreas
8. Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions
9. Relation of pancreatic duct hyperplasia to carcinoma
10. Hyperplastic, preneooplastic and neoplastic lesions found in 83 human pancreases
11. Varying grades of epithelial atypia in the pancreatic ducts of humans: Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen
12. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
13. Inactivation of the pl6 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
14. Overexpression of p53 protein in adenocarcinoma of the pancreas
15. Immunohistochemical evaluation of HER-2/neu oncogene expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms
16. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation
17. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
18. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
19. Expression of p53 nucleophosphoprotein in in situ pancreatic ductal adenocarcinoma: An immunohistochemical analysis of 100 cases
20. Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic and peripancreatic adenocarcinomas: A new marker of DPC4 inactivation
21. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium
22. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines
23. MUCin (Muc) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: A potential role of MUC4 as a tumor marker of diagnostic significance
24. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues
25. Selection of tumor antigens as targets for immune attack using immunohistochemistry: Protein antigens
26. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
27. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma
28. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma
29. Expression of mucin antigens in human cancers and its relationship with malignancy potential
30. Retinoic acid-dependent transforming growth factor-beta2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway
31. Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization
32. Mucin gene expression in the human endocervix
33. MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix
34. Developmental mucin gene expression in the human respiratory tract
35. Developmental expression of mucin genes in the human gastrointestinal system
36. MUC4 mRNA in peripheral blood mononuclear cells (PBMC) as a potential tumor marker for pancreatic cancer
37. Circulating breast cancer cells are frequently apoptotic